Actively Recruiting

Phase Not Applicable
Age: 18Years - 65Years
All Genders
Healthy Volunteers
NCT07242105

Optimizing Brain Excitability in Depression

Led by Stanford University · Updated on 2026-02-10

145

Participants Needed

2

Research Sites

214 weeks

Total Duration

On this page

Sponsors

S

Stanford University

Lead Sponsor

N

National Institute of Mental Health (NIMH)

Collaborating Sponsor

AI-Summary

What this Trial Is About

The goal of this study is to improve depression treatment by establishing reliable prefrontal excitability markers through Targeting with Automated Real-time Guidance for Enhancing TEPs (TARGET).

CONDITIONS

Official Title

Optimizing Brain Excitability in Depression

Who Can Participate

Age: 18Years - 65Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Men and women, ages 18 to 65
  • Diagnosis of major depressive disorder confirmed by Structured Clinical Interview for DSM-5 (SCID-5)
  • Currently in a depressive episode as assessed by SCID-5
  • Moderate-to-severe depression indicated by Quick Inventory of Depressive Symptoms (QIDS) score between 11 and 20
  • Able to understand English well to follow EEG and TMS instructions and clinical assessments
  • No current or past neurological disorders
  • No seizure disorder or risk of seizures
  • Neurosurgical patients with medication-refractory epilepsy admitted for phase II intracranial monitoring, aged 18 to 65, able to understand consent and agree to study participation
Not Eligible

You will not qualify if you...

  • Contraindications for MRI such as implanted metal
  • History of head trauma with loss of consciousness
  • History of seizures or use of medications that lower seizure threshold (e.g., olanzapine, chlorpromazine, lithium)
  • Presence of neurological or uncontrolled medical disease
  • Any unstable medical condition
  • Active substance abuse
  • Diagnosis of psychotic or bipolar disorder
  • Previous failure of Electroconvulsive Therapy (ECT)
  • Suicide attempt within the past year
  • Currently pregnant or breastfeeding
  • Received repetitive Transcranial Magnetic Stimulation (rTMS) treatment in the past six months

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

University of Iowa

Iowa City, California, United States, 52246

Actively Recruiting

2

Stanford University

Stanford, California, United States, 94305

Actively Recruiting

Loading map...

Research Team

J

Jade T Truong, BS

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

CROSSOVER

Primary Purpose

BASIC_SCIENCE

Number of Arms

4

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here